Discovery of key protein behind cancer relapse and progression can lead to new therapies
Tuesday, June 30, 2020 - 12:30
in Health & Medicine
Reports show that cancer is the second-highest leading cause of death globally. A recent study by scientists provides new evidence supporting the presence of a key mechanism behind progression and relapse in cancer. The study discusses the role of MBNL1 protein as a biomarker for cancer prognosis, which can lead to the development of new treatment strategies for cancer.